Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction

JACC: Cardiovascular Interventions

Volumn 4, Issue 3, 2011, Pages 281-286

  Sørensen, Morten V ^a   Pedersen, Sune ^b   Møgelvang, Rasmus ^b   Skov Jensen, Jan ^b,c   Flyvbjerg, Allan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

high mobility group box 1; ischemia; ischemic reperfusion injury; myocardial infarction; receptor for advanced glycation end products

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; HIGH MOBILITY GROUP B1 PROTEIN; TROPONIN I;

AGE; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DENMARK; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HMGB1 PROTEIN; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 79953016177     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.10.015     Document Type: Article

References (27)

1. T. Gaziano, K.S. Reddy, F. Paccaud, S. Horton, and V. Chaturvedi Cardiovascular diseases Chapter 33 D.T. Jamison, Disease Control Priorities in Developing Countries 2nd edition 2006 World Bank Washington, DC 645 662
2. H.R. Andersen, T.T. Nielsen, K. Rasmussen DANAMI-2 Investigators A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 2003 733 742 (Pubitemid 37010777)
3. W.E. Boden, K. Eagle, and C.B. Granger Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options J Am Coll Cardiol 50 2007 917 929 (Pubitemid 47313604)
4. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 2003 13 20 (Pubitemid 36050955)
5. F.S. Apple, A.H. Wu, J. Mair Committee on Standardization of Markers of Cardiac Damage of the IFCC Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome Clin Chem 51 2005 810 824 (Pubitemid 40577917)
6. R. Bolli, L. Becker, G. Gross NHLBI Working Group on the Translation of Therapies for Protecting the Heart from Ischemia Myocardial protection at a crossroads: the need for translation into clinical therapy Circ Res 95 2004 125 134 (Pubitemid 38988678)
7. M.T. Dirksen, G.J. Laarman, M.L. Simoons, and D.J. Duncker Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies Cardiovasc Res 74 2007 343 355 (Pubitemid 46693697)
8. L. Gomez, H. Thibault, and A. Gharib Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice Am J Physiol Heart Circ Physiol 293 2007 H1654 H1661
9. E.K. Iliodromitis, M. Georgiadis, M.V. Cohen, J.M. Downey, E. Bofilis, and D.T. Kremastinos Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs Basic Res Cardiol 101 2006 502 507 (Pubitemid 44637866)
10. D.M. Yellon, and D.J. Hausenloy Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
11. J.R. Klune, T.R. Billiar, and A. Tsung HMGB1 preconditioning: therapeutic application for a danger signal? J Leukoc Biol 83 2008 558 563 (Pubitemid 351966865)
12. I.E. Dumitriu, P. Baruah, A.A. Manfredi, M.E. Bianchi, and P. Rovere-Querini HMGB1: guiding immunity from within Trends Immunol 26 2005 381 387 (Pubitemid 40835844)
13. J.S. Park, D. Svetkauskaite, and Q. He Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370 7377 (Pubitemid 38294612)
14. R. Ramasamy, S.F. Yan, and A.M. Schmidt Stopping the primal RAGE reaction in myocardial infarction: capturing adaptive responses to heal the heart? Circulation 117 2008 3165 3167
15. M. Andrassy, H.C. Volz, and J.C. Igwe High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 2008 3216 3226
16. S. Oozawa, S. Mori, and T. Kanke Effects of HMGB1 on ischemia-reperfusion injury in the rat heart Circ J 72 2008 1178 1184 (Pubitemid 351957089)
17. T. Kitahara, Y. Takeishi, and M. Harada High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice Cardiovasc Res 80 2008 40 46
18. A. Germani, F. Limana, and M.C. Capogrossi Pivotal advances: high-mobility group box 1 proteina cytokine with a role in cardiac repair J Leukoc Biol 81 2007 41 45 (Pubitemid 46021250)
19. T. Kohno, T. Anzai, and K. Naito Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling Cardiovasc Res 81 2009 565 573
20. R.S. Goldstein, M. Gallowitsch-Puerta, and L.H. Yang Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia Shock 25 2006 571 574 (Pubitemid 44297016)
21. H. Wahl, R.B. de Neegaard, P. Schnohr, and G. Jensen [Diet in 4049-year-old persons in Copenhagen in 1977. The Osterbro study.] Ugeskr Laeger 141 1979 51 53 (Pubitemid 9076626)
22. A. Kaltoft, M. Bøttcher, and S.S. Nielsen Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial Circulation 114 2006 40 47 (Pubitemid 44305273)
23. H. Kelbæk, C.J. Terkelsen, and S. Helqvist Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial J Am Coll Cardiol 51 2008 899 905 (Pubitemid 351282452)
24. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251 (Pubitemid 29329996)
25. A. Tsung, R. Sahai, and H. Tanaka The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusin J Exp Med 201 2005 1135 1143 (Pubitemid 40524681)
26. E. Abraham, J. Arcaroli, A. Carmody, H. Wang, and K.J. Tracey HMG-1as a mediator of acute lung inflammation J Immunol 165 2000 2950 2954
27. F. Giallauria, P. Cirillo, and R. Lucci Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction Atherosclerosis 208 2010 280 284